🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06250699
Recruiting Not applicable

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

NCT06250699 · tracked via the Priya Life Science China tracker
Sponsor
Zhe Meng
Phase
Not applicable
Started
2024-01-03
Last updated
2024-02-13

Condition(s) studied

Nonfunctional Adrenal Cortex AdenomaPrimary AldosteronismCushing Syndrome

Investigational drug(s) / intervention(s)

Tubeless laparoscopic adrenalectomyDrainage tube

Tubeless laparoscopic adrenalectomy: No drainage tube placed after laparoscopic adrenalectomy

Drainage tube: Placing drainage tubes after laparoscopic adrenalectomy

Study summary

The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are:

1. The safety of tubeless laparoscopic adrenalectomy;
2. The role of tubeless therapy in rapid recovery after adrenalectomy surgery Participants will be randomly divided into two groups: the non drainage group and the drainage group after laparoscopic adrenal surgery, and their pain, first time out of bed, and intestinal recovery time will be observed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: 1. According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications 2. The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old. Exclusion Criteria: 1. Patients with complications that seriously affect treatment or quality of life 2. The patient has any physical condition that the researcher believes will affect the clinical status 3. Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year 4. Pregnant or lactating patients

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongnan hospital Wuhan Hubei Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06250699 on ClinicalTrials.gov ↗ ← All trials in China